Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.
Related Research units
Bibliographical data
| Original language | English |
|---|---|
| Article number | 11 |
| ISSN | 0946-1965 |
| Publication status | Published - 2004 |
| pubmed | 15598036 |
|---|
